CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $74.78 billion. The enterprise value is $143.49 billion.
| Market Cap | 74.78B |
| Enterprise Value | 143.49B |
Important Dates
The next confirmed earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | Jul 22, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -1.86% in one year.
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | -1.86% |
| Shares Change (QoQ) | -2.01% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 82.02% |
| Float | 1.25B |
Valuation Ratios
The trailing PE ratio is 10.45 and the forward PE ratio is 8.12. CVS Health's PEG ratio is 1.00.
| PE Ratio | 10.45 |
| Forward PE | 8.12 |
| PS Ratio | 0.21 |
| Forward PS | 0.20 |
| PB Ratio | 1.01 |
| P/FCF Ratio | 9.19 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.36, with an EV/FCF ratio of 17.63.
| EV / Earnings | 19.60 |
| EV / Sales | 0.40 |
| EV / EBITDA | 11.36 |
| EV / EBIT | 11.36 |
| EV / FCF | 17.63 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.81 |
| Quick Ratio | 0.54 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 6.48 |
| Debt / FCF | 10.05 |
| Interest Coverage | 4.54 |
Financial Efficiency
Return on equity (ROE) is 9.80% and return on invested capital (ROIC) is 6.00%.
| Return on Equity (ROE) | 9.80% |
| Return on Assets (ROA) | 2.90% |
| Return on Capital (ROIC) | 6.00% |
| Revenue Per Employee | $1.20M |
| Profits Per Employee | $24,403 |
| Employee Count | 300,000 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 17.76 |
Taxes
In the past 12 months, CVS Health has paid $2.52 billion in taxes.
| Income Tax | 2.52B |
| Effective Tax Rate | 25.64% |
Stock Price Statistics
The stock price has decreased by -19.91% in the last 52 weeks. The beta is 0.51, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -19.91% |
| 50-Day Moving Average | 58.50 |
| 200-Day Moving Average | 69.16 |
| Relative Strength Index (RSI) | 51.57 |
| Average Volume (20 Days) | 9,364,476 |
Short Selling Information
The latest short interest is 18.43 million, so 1.47% of the outstanding shares have been sold short.
| Short Interest | 18.43M |
| Short Previous Month | 17.71M |
| Short % of Shares Out | 1.47% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 1.47 |
Income Statement
In the last 12 months, CVS Health had revenue of $360.94 billion and earned $7.32 billion in profits. Earnings per share was $5.70.
| Revenue | 360.94B |
| Gross Profit | 53.62B |
| Operating Income | 12.57B |
| Pretax Income | 9.85B |
| Net Income | 7.32B |
| EBITDA | 12.63B |
| EBIT | 12.63B |
| Earnings Per Share (EPS) | $5.70 |
Balance Sheet
The company has $13.09 billion in cash and $81.79 billion in debt, giving a net cash position of -$68.70 billion or -$54.73 per share.
| Cash & Cash Equivalents | 13.09B |
| Total Debt | 81.79B |
| Net Cash | -68.70B |
| Net Cash Per Share | -$54.73 |
| Equity (Book Value) | 73.97B |
| Book Value Per Share | 58.92 |
| Working Capital | -15.85B |
Cash Flow
In the last 12 months, operating cash flow was $10.89 billion and capital expenditures -$2.75 billion, giving a free cash flow of $8.14 billion.
| Operating Cash Flow | 10.89B |
| Capital Expenditures | -2.75B |
| Free Cash Flow | 8.14B |
| FCF Per Share | $6.46 |
Margins
Gross margin is 14.86%, with operating and profit margins of 3.48% and 2.03%.
| Gross Margin | 14.86% |
| Operating Margin | 3.48% |
| Pretax Margin | 2.73% |
| Profit Margin | 2.03% |
| EBITDA Margin | 3.50% |
| EBIT Margin | 3.50% |
| FCF Margin | 2.25% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 4.47%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 4.47% |
| Dividend Growth (YoY) | 9.94% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 46.67% |
| Buyback Yield | 1.86% |
| Shareholder Yield | 6.32% |
| Earnings Yield | 9.79% |
| FCF Yield | 10.88% |
Analyst Forecast
The average price target for CVS Health is $76.10, which is 27.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $76.10 |
| Price Target Difference | 27.75% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 4.99% |
| EPS Growth Forecast (5Y) | 10.38% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 6 |